Evidence map›Paper›PMID 40678509›Full record

ArticleiScience2025

Deep learning enhanced deciphering of brain activity maps for discovery of therapeutics for brain disorders.

Xianrui Zhang, Zhen Liu, Xuan Luo, Yi Cao, Wencong Zhang, Honglin Li, Wei Li, Shuk Han Cheng, Stephen J Haggarty, Xin Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xianrui ZhangDepartment of Biomedical Science, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.
Zhen LiuDepartment of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.
Xuan LuoDepartment of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.
Yi CaoDepartment of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR 999077, China.
Wencong ZhangDepartment of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.
Honglin LiInnovation Center for AI and Drug Discovery, East China Normal University, Shanghai 200062, China.
Wei LiSchool of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
Shuk Han ChengDepartment of Biomedical Science, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.
Stephen J HaggartyChemical Neurobiology Laboratory, Precision Therapeutics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, MA 02114, USA.
Xin WangDepartment of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR 999077, China.
Peng ShiDepartment of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong SAR 999077, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents an artificial intelligence enhanced

Indexed as

Biomedical EngineeringPharmacology

Identifiers

PMID40678509
PMCPMC12268937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.